Cargando…
Prolonged extrapyramidal symptoms induced by long‐term, intermittent administration of low‐dose olanzapine along with metoclopramide for emesis: A case report
BACKGROUND: Antipsychotics with dopamine (D2) receptor antagonism can be effective for emesis in cancer patients. Extrapyramidal symptoms (EPS) induced by typical antipsychotics can be exacerbated by other D2 receptor antagonists. We describe a case of persistent EPS induced by long‐term, intermitte...
Autores principales: | Sakamoto, Shoko, Deguchi, Yasuhiko, Uchida, Sawako, Itoh, Yoshiaki, Inoue, Koki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515702/ https://www.ncbi.nlm.nih.gov/pubmed/35716124 http://dx.doi.org/10.1002/npr2.12277 |
Ejemplares similares
-
Ondansetron compared with ondansetron plus metoclopramide in the prevention of cisplatin-induced emesis.
por: Lee, C. W., et al.
Publicado: (1994) -
Isolated Lingual Dystonia as the Manifestation of Acute Extrapyramidal Syndrome Induced by Metoclopramide
por: Verma, Rajesh, et al.
Publicado: (2019) -
Baricitinib/ceftriaxone/metoclopramide: Extrapyramidal syndrome and off label use: case report
Publicado: (2021) -
Extrapyramidal side effects after metoclopramide administration in a post-anesthesia care unit -A case report-
por: Jo, Youn Yi, et al.
Publicado: (2012) -
The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.
por: O'Brien, M. E., et al.
Publicado: (1989)